Image

Endocrine system cancers - adrenocortical

About
Risks
Symptoms
Diagnosis
Prevention

Adrenocortical cancer (ACC) is a rare malignancy arising from the adrenal cortex, the outer layer of the adrenal glands situated on top of each kidney. This type of cancer can be aggressive and may produce excess hormones that lead to endocrine imbalances, affecting the body's metabolism and overall hormonal health. Symptoms can vary based on the type of hormones produced, and the prognosis often depends on the stage at diagnosis as well as surgical resectability.

Several risk factors have been identified that may increase the likelihood of developing adrenocortical cancer, including genetic predispositions such as Li-Fraumeni syndrome and Beckwith-Wiedemann syndrome. Additionally, previous adrenal benign tumors, certain congenital adrenal hyperplasia forms, and exposure to radiation may elevate risk. However, the overall incidence remains low, making it a rare clinical challenge.

Patients with adrenocortical cancer may experience a variety of symptoms depending on hormone hypersecretion, which can include weight gain, hypertension, and changes in hair growth patterns. Common presentations may also involve abdominal pain, palpable masses, or unintentional weight loss as the disease progresses. Due to its symptoms being nonspecific, ACC can often be misdiagnosed or diagnosed at a more advanced stage.

Adrenocortical cancer primarily arises from the adrenal glands, which produce hormones critical for various bodily functions. While the exact cause is often unknown, certain genetic predispositions, such as Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, and familial adenomatous polyposis, have been identified as risk factors. Other contributing factors may include chronic exposure to certain chemicals, as well as a history of adrenal tumors or disorders.

The diagnosis of adrenocortical cancer typically involves imaging studies such as CT or MRI scans to identify tumors, followed by biochemical tests to assess hormone levels. Fine needle aspiration or surgical biopsy may be necessary to provide a definitive diagnosis and characterize the tissue. Tumor staging is often conducted to determine the extent of disease spread, guiding treatment options and prognosis.

Treatment for adrenocortical cancer typically involves surgical resection of the tumor, which is the most effective approach for localized disease. If the cancer has spread, options may include chemotherapy, targeted therapies, and radiation. Management strategies are personalized based on tumor characteristics, stage of the disease, and overall patient health, and often involve a multidisciplinary team to optimize outcomes.

Currently, there are no established preventive measures specific to adrenocortical cancer due to its rarity, and no effective screening guidelines exist. However, managing known risk factors, such as genetic predispositions through genetic counseling and surveillance, may help in early detection. Maintaining a healthy lifestyle with regular monitoring for individuals with pertinent risk factors is advisable to reduce overall cancer risk.
On this page